Directory

>

Michael Scannell

Michael Scannell

Vice President, Chemistry and CMC | Longboard Pharmaceuticals

Holly Springs, North Carolina, United States

View contact details (it's free)

Michael Scannell

Summary

Michael Scannell is a seasoned professional in the pharmaceutical industry, currently serving as Vice President of Chemistry and CMC at Longboard Pharmaceuticals. With a Ph.D. in Chemistry from the University of Maryland, he has amassed extensive experience in analytical chemistry and drug development over a career spanning more than two decades. His leadership roles at various companies demonstrate his capability in managing complex projects and teams, particularly in clinical development and regulatory strategies. Michael has a proven track record of establishing methodologies that support both small and large molecule therapies. His expertise extends to technology transfer and toxicology, making him a valuable asset in the life sciences sector. Passionate about innovation, he continuously seeks to improve processes and outcomes in drug manufacturing. Michael's diverse experience across different organizations highlights his adaptability and commitment to advancing pharmaceutical sciences.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Michael Scannell

Work Experience

company logo

Vice President, Chemistry and CMC at

Longboard Pharmaceuticals

March 2023 - Present

company logo

Head, Chemistry and CMC Development at

Longboard Pharmaceuticals

January 2022 - March 2023

company logo

Sr. Director, CMC Development at

Esperion

December 2019 - January 2022

💼

Director, Analytical Development at

Molecular Skin Therapy, Incorporated

May 2018 - December 2019

company logo

Senior Director, Analytical Sciences at

United Therapeutics Corporation

March 2014 - March 2018

company logo

Director, Analytical Sciences at

United Therapeutics Corporation

January 2011 - March 2014

company logo

Director, Chemical and Pharmaceutical Development at

SCYNEXIS, Inc.

August 2007 - January 2011

company logo

Director, Chemical and Analytical Development at

SCYNEXIS, Inc.

August 2000 - October 2008

💼

Senior Scientist at

Hauser Chemical Research

June 1998 - July 2000

💼

Senior Scientist at

Parker Hughes Institute

January 1997 - January 1998

Logos provided by Logo.dev

Michael Scannell

Education

The University of Maryland, College Park, Doctor Of Philosophy (Ph.D.)

January 1992 - January 1996

Towson University, Bachelor's Degree

Frequently Asked Questions about Michael Scannell

What is Michael Scannell email address?

Michael Scannell's primary email address is *********@longboardpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Michael Scannell work for?

Michael Scannell is a Vice President, Chemistry and CMC at Longboard Pharmaceuticals, a company specializing in Commercial physical research.

Where Michael Scannell graduated from?

Michael Scannell holds a degree in Chemistry from The University of Maryland, College Park.

How can I directly contact Michael Scannell?

To contact Michael Scannell directly, you can use the email address *********@longboardpharma.com. Complete contact information is available upon registration with Muraena.

Who is Michael Scannell?

Michael Scannell is a seasoned professional in the pharmaceutical industry, currently serving as Vice President of Chemistry and CMC at Longboard Pharmaceuticals. With a Ph.D. in Chemistry from the University of Maryland, he has amassed extensive experience in analytical chemistry and drug development over a career spanning more than two decades. His leadership roles at various companies demonstrate his capability in managing complex projects and teams, particularly in clinical development and regulatory strategies. Michael has a proven track record of establishing methodologies that support both small and large molecule therapies. His expertise extends to technology transfer and toxicology, making him a valuable asset in the life sciences sector. Passionate about innovation, he continuously seeks to improve processes and outcomes in drug manufacturing. Michael's diverse experience across different organizations highlights his adaptability and commitment to advancing pharmaceutical sciences.

Michael`s contact details

mail

*********@longboardpharma.com

*********@unither.com

Colleagues

avatar
Taylor Boyd

Vice President - Head of Business Development

avatar
Anne Danks

Vice President, Nonclinical Research and Development

avatar
Randall Kaye

Chief Medical Officer

avatar
Dewey Mclin

Vice President, Medical Affairs

avatar
Julie Baker

Vice President Commercial Strategy

avatar
Kevin Lind

President and CEO

avatar
Chad Orevillo

Executive Vice President, Head of Operations

avatar
Megan Knight

Vice President, Head of Investor Relations

avatar
Phillip Schneider

Director and Audit Committee Chair

avatar
Marianne Tschudi

Vice President & General Manager Europe / International

View Contact details (it's free)
Request Profile Removal